War on Cancer Asia 2019: Better advocacy, better care is organized by The Economist Events and will be held on Mar 28, 2019 at One Farrer Hotel and Spa, Singapore.

The target audience for this medical event is practitioner, and provider communities with policymakers, patients, advocates, NGOs and civil society, to share best practice and to create a manifesto for change. This CME Conference has been approved for a maximum of 5.5 CPD points.

Conference Description:
The War on Cancer Asia Summit is part of our global initiative to catalyse fresh debate and drive progress in cancer control. The event will gather a diverse audience from the medical, practitioner, and provider communities, together with policymakers, patients, advocates, NGOs and civil society. We will examine the state of play of National Cancer Control Plans across Asia, explore best practices and areas for improvement, and create a manifesto for accelerated action and change.

Patient groups are beginning to emerge across Asia, and patient advocacy is starting to find its voice. Against the backdrop of a rising cancer burden and increasing demand for quality care, the summit will aim to accelerate the pace of patient advocacy across the region to drive better care and policy. We will draw on case studies showing effective collaboration among advocacy groups, and between advocacy groups and policymakers. The summit will explore where working together has transformed policies and practices in prevention, early detection, treatment and care. We will also examine the potential pitfalls as we place these examples in the regional context.

A mantra on the role of advocacy in modern health care systems asserts: “No decision about me, without me.” Our mission is to create a workable vision that points the way towards making this mantra a reality for cancer care in Asia. Join us and add your support.

Why Attend
Join us at the War on Cancer Asia, on March 28th in Singapore, a diverse audience from the medical, practitioner, and provider communities with policymakers, patients, advocates, NGOs and civil society, to share best practice and to create a manifesto for change.

Topics:
• What is the state of play for cancer control in Asia-Pacific?
• How well prepared are Asian countries for the rising cancer burden and increasing demand for quality care?
• What can patient advocacy realistically achieve?
• What does the concept of advocacy mean in the Asia-Pacific region?
• How can we increase collaboration to drive real change? Who needs to be involved?
• What needs to happen to achieve the mantra: “no decision about me, without me”?
• How can promising progress in diagnostics help more people?

Speakers:

Charles Goddard, editorial director, Asia Pacific, The Economist Intelligence Unit, Vivek Muthu, chief healthcare adviser, The Economist Intelligence Unit, Patricia Garcia-Gonzalez, chief executive, Max Foundation, Tan-Min Han, chief executive, Lucence Diagnostics, Dhairyasheel Savant, president, Indian Association of Surgical Oncology, Chng Wee Joo, director, National University Cancer Institute, Singapore, Kenneth Fleming, emeritus fellow, Green Templeton College, University of Oxford, Sarunas Narbutas, president, Lithuanian Cancer Patient Coalition, Sadir Alrawi, director of surgical oncology services, Alzahra Cancer Center, Richard Lim Boon Leong, national advisor for palliative medicine, Ministry of Health, Malaysia

Time: 8:00 am - 5:45 pm